MR/M009092/1/MRC_/Medical Research Council/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2014	3
2015	28
2016	28
2017	9
2018	1
2019	9
2020	9
2021	2
2022	2
2023	1
2024	0

1

Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-¹³ C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade.

Chowdhury R, Mueller CA, Smith L, Gong F, Papoutsaki MV, Rogers H, Syer T, Singh S, Brembilla G, Retter A, Bullock M, Caselton L, Mathew M, Dineen E, Parry T, Hennig J, von Elverfeldt D, Schmidt AB, Hövener JB, Emberton M, Atkinson D, Bainbridge A, Gadian DG, Punwani S. Chowdhury R, et al. J Magn Reson Imaging. 2023 Jun;57(6):1865-1875. doi: 10.1002/jmri.28467. Epub 2022 Oct 31. J Magn Reson Imaging. 2023. PMID: 36315000 Free PMC article.

2

Image-Guided Magnetic Thermoseed Navigation and Tumor Ablation Using a Magnetic Resonance Imaging System.

Baker RR, Payne C, Yu Y, Mohseni M, Connell JJ, Lin F, Harrison IF, Southern P, Rudrapatna US, Stuckey DJ, Kalber TL, Siow B, Thorne L, Punwani S, Jones DK, Emberton M, Pankhurst QA, Lythgoe MF. Baker RR, et al. Adv Sci (Weinh). 2022 Apr;9(12):e2105333. doi: 10.1002/advs.202105333. Epub 2022 Feb 2. Adv Sci (Weinh). 2022. PMID: 35106965 Free PMC article.

3

Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis.

Stabile A, Mazzone E, Cirulli GO, De Cobelli F, Grummet J, Thoeny HC, Emberton M, Pokorny M, Pinto PA, Taneja SS. Stabile A, et al. Eur Urol Oncol. 2021 Aug;4(4):519-528. doi: 10.1016/j.euo.2020.11.008. Epub 2020 Dec 28. Eur Urol Oncol. 2021. PMID: 33384275 Review.

4

Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out.

Norris JM, Carmona Echeverria LM, Simpson BS, Ball R, Freeman A, Kelly D, Kirkham A, Stavrinides V, Whitaker HC, Emberton M. Norris JM, et al. BJU Int. 2021 Feb;127(2):169-170. doi: 10.1111/bju.15295. Epub 2020 Dec 1. BJU Int. 2021. PMID: 33185024 No abstract available.

5

Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial.

Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V; PRECISION study group. Giganti F, et al. Eur Urol Oncol. 2020 Oct;3(5):615-619. doi: 10.1016/j.euo.2020.06.007. Epub 2020 Jul 6. Eur Urol Oncol. 2020. PMID: 32646850 Clinical Trial.

6

Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study.

Bosaily AE, Frangou E, Ahmed HU, Emberton M, Punwani S, Kaplan R, Brown LC, Freeman A, Jameson C, Hindley R, Peppercorn D, Thrower A, Winkler M, Barwick T, Stewart V, Burns-Cox N, Burn P, Ghei M, Kumaradevan J, Prasad R, Ash-Miles J, Shergill I, Agarwal S, Rosario D, Salim F, Bott S, Evans H, Henderson A, Ghosh S, Dudderidge T, Smart J, Tung K, Kirkham A; PROMIS Group. Bosaily AE, et al. Eur Urol. 2020 Oct;78(4):503-511. doi: 10.1016/j.eururo.2020.03.002. Epub 2020 Apr 18. Eur Urol. 2020. PMID: 32312543

7

Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol.

Norris JM, Kasivisvanathan V, Allen C, Ball R, Freeman A, Ghei M, Kirkham A, Whitaker HC, Kelly D, Emberton M. Norris JM, et al. Methods Protoc. 2020 Mar 28;3(2):26. doi: 10.3390/mps3020026. Methods Protoc. 2020. PMID: 32231090 Free PMC article.

8

DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations.

Giganti F, Pecoraro M, Fierro D, Campa R, Del Giudice F, Punwani S, Kirkham A, Allen C, Emberton M, Catalano C, Moore CM, Panebianco V. Giganti F, et al. Magn Reson Imaging. 2020 Apr;67:50-58. doi: 10.1016/j.mri.2019.12.007. Epub 2019 Dec 30. Magn Reson Imaging. 2020. PMID: 31899283

9

Magnetic Resonance Imaging Should Be Used in the Active Surveillance of Patients with Localised Prostate Cancer.

Kasivisvanathan V, Giganti F, Emberton M, Moore CM. Kasivisvanathan V, et al. Eur Urol. 2020 Mar;77(3):318-319. doi: 10.1016/j.eururo.2019.11.014. Epub 2019 Nov 25. Eur Urol. 2020. PMID: 31780103 No abstract available.

10

Translating cost-utility modelling into the real world - the case of focal high-intensity focussed ultrasound and active surveillance.

Emberton M. Emberton M. BJU Int. 2019 Dec;124(6):900-901. doi: 10.1111/bju.14918. BJU Int. 2019. PMID: 31769142 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year